Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (950)
1
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer : A Phase III Open-label, Multicenter, Randomized Trial of Adjuvant Palbociclib in Combination With Endocrine Therapy Versus Endocrine Therapy Alone for Patients With Hormone Receptor Positive / HER2-negative Resected Isolated Locoregional Recurrence of Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) : A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer : A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer : A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Hypofractionated LocoRegional Radiotherapy in Breast Cancer : Randomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast Cancer and Lymphedema (RHEAL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer : A Double-blind, Randomized, Placebo-controlled Multicenter Study to Investigate Efficacy and Safety of Elinzanetant for the Treatment of Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy, Over 52 Weeks and Optionally for Additional 2 Years in Women With Hormone-receptor Positive Breast Cancer:
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation : An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study : Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer : A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. : A Randomized, Multicenter, Double-Blind, Parallel-Controlled, Phase III Clinical Study to Evaluate QL1209/Pertuzumab in Combination With Docetaxel in Patients With Early-Stage or Locally Advanced HER2-Positive and ER/PR-negative Breast Cancer.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[95]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Phase: Phase 3
Medienart
950
Aufsätze
950
E-Artikel
950
E-Ressourcen
Zeitschriftentitel
950
ClinicalTrials.gov
Thema
950
610
Breast Neoplasms
Phase: Phase 3
950
Study Type: Interventional
390
Recruitment Status: Completed
264
Medical Condition: Breast Cancer
211
Recruitment Status: Recruiting
147
Recruitment Status: Active, not recruiting
80
Triple Negative Breast Neoplasms
72
Recruitment Status: Unknown status
59
Recruitment Status: Terminated
44
Recruitment Status: Not yet recruiting
27
Carcinoma
27
Medical Condition: Metastatic Breast Cancer
22
Medical Condition: Breast Neoplasms
22
Neoplasms
21
Neoplasm Metastasis
20
Recurrence
18
Recruitment Status: Withdrawn
14
Carcinoma, Ductal, Breast
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
581
2020-
342
2010-2019
27
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
950
Englisch
Haven't found what you're looking for?
Wird geladen...